EcoDrugPlus

Cyclin D1

Ensembl ID : ENSTNIG00000014196
Gene Symbol: CCND1
2 Cross references
232 Possible Orthologues:

Cyclin-Dependent Kinase 1

Ensembl ID : ENSTNIG00000003176
Gene Symbol: CDK1
2 Cross references
247 Possible Orthologues:

Cyclin-Dependent Kinase 2

Ensembl ID : ENSTNIG00000018250
Gene Symbol: CDK2
2 Cross references
202 Possible Orthologues:

Cyclin-Dependent Kinase 4

Ensembl ID : ENSTNIG00000018240
Gene Symbol: CDK4
2 Cross references
238 Possible Orthologues:

Cyclin-Dependent Kinase 6

Ensembl ID : ENSTNIG00000017771
Gene Symbol: CDK6
2 Cross references
200 Possible Orthologues:

Cyclin-Dependent Kinase 7

Ensembl ID : ENSTNIG00000015407
Gene Symbol: CDK7
2 Cross references
218 Possible Orthologues:

Cyclin-Dependent Kinase 9 (Cdc2-Related Kinase)

Ensembl ID : ENSTNIG00000018657
Gene Symbol: CDK9
2 Cross references
206 Possible Orthologues:

Cyclin-Dependent Kinase 9 (Cdc2-Related Kinase)

Ensembl ID : ENSTNIG00000002426
Gene Symbol: CDK9
2 Cross references
206 Possible Orthologues:

Cytidine Deaminase B

Ensembl ID : ENSTNIG00000000062
Gene Symbol: CDAB
2 Cross references
200 Possible Orthologues:

Cytochrome P450 Family 19 Subfamily A Member 1

Ensembl ID : ENSTNIG00000013690
Gene Symbol: CYP19A1
3 Cross references
244 Possible Orthologues:

Cytochrome P450, Family 17, Subfamily A, Polypeptide 1

Ensembl ID : ENSTNIG00000019678
Gene Symbol: CYP17A1
2 Cross references
210 Possible Orthologues:

Cytochrome P450, Family 19, Subfamily A, Polypeptide 1a

Ensembl ID : ENSTNIG00000009520
Gene Symbol: CYP19A1A
2 Cross references
249 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).